» Articles » PMID: 21853265

Gut Microbiota of Healthy Elderly NSAID Users is Selectively Modified with the Administration of Lactobacillus Acidophilus NCFM and Lactitol

Overview
Journal Age (Dordr)
Publisher Springer
Specialty Geriatrics
Date 2011 Aug 20
PMID 21853265
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Ageing changes gut microbiota composition and alters immune system function. Probiotics, prebiotics and synbiotics may improve the health status of elderly individuals by modifying the intestinal environment and the microbiota composition, and by stimulating the immune system. In this work, we studied the effects of synbiotic supplementation on the gut microbiota of healthy elderly volunteers. Fifty-one elders were randomly assigned to consume either a synbiotic dietary supplement or a placebo in addition to their usual diet for a 2-week period. The synbiotic product consisted of the probiotic Lactobacillus acidophilus NCFM and the prebiotic lactitol and was ingested twice a day, with a total daily dose of 10 g lactitol and 2 × 10(10) cells of probiotic bacteria. Before, during and after the intervention period fecal quantities of six phylogenetic bacterial groups were determined using quantitative PCR, and relative changes in total microbiota composition were assessed by percent guanine-plus-cytosine profiling. The microbiota profiles showed certain relative changes within the microbial community, and indicated an increase of bifidobacteria levels during synbiotic supplementation. Quantification by PCR confirmed the in changes in the microbiota composition; for example increases in total levels of endogenous bifidobacteria and lactobacilli were recorded. Throughout the 6-week study period there was a decrease unrelated to intervention in the Blautia coccoides-Eubacterium rectale bacterial group levels and Clostridium cluster XIVab levels, but this decrease appeared to be halted during the synbiotic intervention. In conclusion, putatively beneficial changes in microbiota were observed in the elderly subjects supplemented with the synbiotic product.

Citing Articles

Unlocking the Microbial Symphony: The Interplay of Human Microbiota in Cancer Immunotherapy Response.

Chacon J, Faizuddin F, McKee J, Sheikh A, Vasquez Jr V, Gadad S Cancers (Basel). 2025; 17(5).

PMID: 40075661 PMC: 11899421. DOI: 10.3390/cancers17050813.


Evidence of the Beneficial Impact of Three Probiotic-Based Food Supplements on the Composition and Metabolic Activity of the Intestinal Microbiota in Healthy Individuals: An Ex Vivo Study.

Sanchez M, Herraiz A, Tigre S, Llama-Palacios A, Hernandez M, Ciudad M Nutrients. 2023; 15(24).

PMID: 38140334 PMC: 10745619. DOI: 10.3390/nu15245077.


Beneficial Effects of Lactic Acid Bacteria on Animal Reproduction Function.

Mahendra M, Dadi T, Kamaludeen J, Pertiwi H Vet Med Int. 2022; 2022:4570320.

PMID: 36505731 PMC: 9729032. DOI: 10.1155/2022/4570320.


The role of the microbiota-gut-brain axis in long-term neurodegenerative processes following traumatic brain injury.

Chiu L, Anderton R Eur J Neurosci. 2022; 57(2):400-418.

PMID: 36494087 PMC: 10107147. DOI: 10.1111/ejn.15892.


Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention.

Campagnoli L, Marchesi N, Vairetti M, Pascale A, Ferrigno A, Barbieri A Cells. 2022; 11(18).

PMID: 36139402 PMC: 9497179. DOI: 10.3390/cells11182827.


References
1.
DelaRosa O, Pawelec G, Peralbo E, Wikby A, Mariani E, Mocchegiani E . Immunological biomarkers of ageing in man: changes in both innate and adaptive immunity are associated with health and longevity. Biogerontology. 2006; 7(5-6):471-81. DOI: 10.1007/s10522-006-9062-6. View

2.
Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J . The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007; 133(1):24-33. DOI: 10.1053/j.gastro.2007.04.005. View

3.
Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery R . Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol. 2009; 30(7):325-33. PMC: 4067971. DOI: 10.1016/j.it.2009.05.004. View

4.
Maukonen J, Satokari R, Matto J, Soderlund H, Mattila-Sandholm T, Saarela M . Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol. 2006; 55(Pt 5):625-633. DOI: 10.1099/jmm.0.46134-0. View

5.
Woodmansey E . Intestinal bacteria and ageing. J Appl Microbiol. 2007; 102(5):1178-86. DOI: 10.1111/j.1365-2672.2007.03400.x. View